Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach

ABSTRACT: This is a single-arm, prospective, Phase II, multi-center clinical trial designed to demonstrate that adaptive radiotherapy for muscle invasive bladder cancer will translate into a decreased rate of acute gastrointestinal toxicity compared with the historically reported rate for non-adaptive intensity modulated radiation therapy (IMRT).

DISEASE(S): Urinary Bladder Neoplasms,Muscle-invasive Bladder Carcinoma

PROVIDER: 2710638 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR